Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human beta-glucuronidase

EU orphan designation number: EU/3/12/973   
Active ingredient: Recombinant human beta-glucuronidase
Indication: Treatment of mucopolysaccharidosis type VII (Sly syndrome)
Sponsor: Ultragenyx UK Limited
c/o Regus, Level 33, 25 Canada Square, Canary Wharf, London E14 5LB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2012 Orphan designation EMA/OD/127/11 (2012)2017 of 21/03/2012
02/01/2014 Transfer of orphan designation EMA/OD/127/11/T/01 (2013)9815 of 20/12/2013
11/05/2015 Transfer of orphan designation EMA/OD/127/11/T/02 (2015)3244 of 07/05/2015